Robotic surgery for gynecologic malignancy is associated with a lower rate of venous thromboembolism (VTE) than laparotomy. Obese patients represent a particularly high-risk group for VTE, but prior studies tend to focus on patients with a much lower BMI and without extended VTE prophylaxis. Our objective was to examine the role of extended thromboprophylaxis in obese patients who underwent robotic-assisted surgery for endometrial cancer. We conducted a retrospective cohort study of obese patients (BMI ≥ 35 kg/m2) who underwent robotic surgery for newly diagnosed endometrial cancer. The primary outcome measured was the occurrence of a VTE event within the 30-day postoperative period. The Farrington–Manning score test was used for equivalence analysis with a 5% margin. Secondary outcomes were perioperative complications. One hundred thirty-two robotic cases for endometrial cancer met our criteria. One hundred twenty-one (92%) received preoperative pharmacologic thromboprophylaxis, and 100% used pneumatic compression devices. Ninety-three percent and 90% received preoperative pharmacologic prophylaxis in the extended and no extended group, respectively (p-value = 0.7). Seventy patients (54%) received 4-week extended prophylaxis. Estimated blood loss was similar in both groups (75 mL vs 60 mL, p-value = 0.6). Perioperative complications and readmissions were similar between the two groups. There were no VTE events during hospital stay. One patient in the group that did not receive extended prophylaxis developed a VTE in the 30-day postoperative period (1.6%), versus 0% in the group that did receive extended prophylaxis (p-value = 0.1). The risk of VTE was low. The absence of extended VTE prophylaxis did not significantly increase the risk for VTE in obese patients with newly diagnosed endometrial cancer who underwent robotic-assisted surgery.
This is a preview of subscription content, log in to check access.
Buy single article
Instant access to the full article PDF.
Price includes VAT for USA
Subscribe to journal
Immediate online access to all issues from 2019. Subscription will auto renew annually.
This is the net price. Taxes to be calculated in checkout.
Bergqvist D, Agnelli G, Cohen AT, Eldor A, Nilsson PE, Le Moigne-Amrani A et al (2002) Duration of prophylaxis against venous thromboembolism with enoxaparin after surgery for cancer. N Engl J Med 346(13):975–980
Geerts WH, Pineo GF, Heit JA, Bergqvist D, Lassen MR, Colwell CW et al (2004) Prevention of venous thromboembolism: the seventh ACCP conference on antithrombotic and thrombolytic therapy. Chest 126(3 Suppl):338S–400S
Sandadi S, Lee S, Walter A, Gardner GJ, Abu-Rustum NR, Sonoda Y et al (2012) Incidence of venous thromboembolism after minimally invasive surgery in patients with newly diagnosed endometrial cancer. Obstet Gynecol 120(5):1077–1083
Kumar S, Al-Wahab Z, Sarangi S, Woelk J, Morris R, Munkarah A et al (2013) Risk of postoperative venous thromboembolism after minimally invasive surgery for endometrial and cervical cancer is low: a multi-institutional study. Gynecol Oncol 130(1):207–212
Bouchard-Fortier G, Geerts WH, Covens A, Vicus D, Kupets R, Gien LT (2014) Is venous thromboprophylaxis necessary in patients undergoing minimally invasive surgery for a gynecologic malignancy? Gynecol Oncol 134(2):228–232
Freeman AH, Barrie A, Lyon L, Littell RD, Garcia C, Conell C et al (2016) Venous thromboembolism following minimally invasive surgery among women with endometrial cancer. Gynecol Oncol 142(2):267–272
Nick AM, Schmeler KM, Frumovitz MM, Soliman PT, Spannuth WA, Burzawa JK et al (2010) Risk of thromboembolic disease in patients undergoing laparoscopic gynecologic surgery. Obstet Gynecol 116(4):956–961
Barber EL, Gehrig PA, Clarke-Pearson DL (2016) Venous thromboembolism in minimally invasive compared with open hysterectomy for endometrial cancer. Obstet Gynecol 128(1):121–126
Mahdi H, Aljebori Q, Lockart D, Moulton L (2016) Risk of venous thromboembolism after laparoscopic surgery for gynecologic malignancy. J Minim Invasive Gynecol 23(7):1057–1062
Key NS, Khorana AA, Kuderer NM, Bohlke K, Lee AYY, Arcelus JI et al (2020) Venous thromboembolism prophylaxis and treatment in patients with cancer: ASCO clinical practice guideline update. J Clin Oncol 38(5):496–520
Vedovati MC, Becattini C, Rondelli F, Boncompagni M, Camporese G, Balzarotti R et al (2014) A randomized study on 1-week versus 4-week prophylaxis for venous thromboembolism after laparoscopic surgery for colorectal cancer. Ann Surg 259(4):665–669
Kim JS, Mills KA, Fehniger J, Liao C, Hurteau JA, Kirschner CV et al (2017) Venous thromboembolism in patients receiving extended pharmacologic prophylaxis after robotic surgery for endometrial cancer. Int J Gynecol Cancer 27(8):1774–1782
Worley MJ Jr, Rauh-Hain JA, Sandberg EM, Muto MG (2013) Venous thromboembolism prophylaxis for laparoscopic surgery: a survey of members of the Society of Gynecologic Oncology. Int J Gynecol Cancer 23(1):208–215
Gould MK, Garcia DA, Wren SM, Karanicolas PJ, Arcelus JI, Heit JA et al (2012) Prevention of VTE in nonorthopedic surgical patients: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest 141(2 Suppl):e227S–e277
Walker JL, Piedmonte MR, Spirtos NM, Eisenkop SM, Schlaerth JB, Mannel RS et al (2009) Laparoscopy compared with laparotomy for comprehensive surgical staging of uterine cancer: Gynecologic Oncology Group Study LAP2. J Clin Oncol 27(32):5331–5336
Laskov I, Kessous R, Abitbol J, Kogan L, Badeghiesh A, Tagalakis V et al (2018) Risk of thromboembolic disease with cost estimates in patients undergoing robotic assisted surgery for endometrial cancer and review of the literature. J Obstet Gynaecol Can 40(12):1571–1579
Leeds IL, Canner JK, DiBrito SR, Safar B (2020) Justifying total costs of extended venothromboembolism prophylaxis after colorectal cancer surgery. J Gastrointest Surg 24(3):677–687
Conflict of interest
Authors SLCM, BD, DS, KTB, LC, YW, SW, JHL, BA, and JCG declare that they have no conflicts of interest.
All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards.
The need for written informed consent was waived by the local institutional review board.
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
About this article
Cite this article
Carbajal-Mamani, S.L., Dideban, B., Schweer, D. et al. Incidence of venous thromboembolism after robotic-assisted hysterectomy in obese patients with endometrial cancer: do we need extended prophylaxis?. J Robotic Surg (2020). https://doi.org/10.1007/s11701-020-01110-6
- Venous thromboembolism
- Endometrial cancer
- Robotic surgery